Glimepiride |
Amaryl |
Glimepiride Systematic (IUPAC) name 3-ethyl-N,N-bis (3-ethyl-4-methyl-2-oxo-5H-pyrrol-2-yl)- 4-methyl-2-oxo-5H-pyrrole-1- carboxamide Identifiers CAS number 93479-97-1 ATC code A10BB12 PubChem 3476 DrugBank APRD00381 Chemical data Formula C24H34N4O5S Mol. weight 490.617 g/mol Pharmacokinetic data Bioavailability ? Protein binding >99.5% Metabolism ? Half life ? Excretion ? Therapeutic considerations Pregnancy cat. ? Le ...
Wikipedia - [full article]
Glimepiride Clinical Trials
- To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1c
ClinicalTrials.gov Identifier: NCT00294723 - Active, not recruiting
Diabetes Mellitus, Type 2
- Exenatide Versus Glimepiride in Patients With Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00359762 - Active, not recruiting
Type 2 Diabetes Mellitus
- Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes.
ClinicalTrials.gov Identifier: NCT00469092 - Active, not recruiting
Diabetes Mellitus, Type 2
- Efficacy and Safety of Inhaled Insulin Compared to Metformin and Glimepiride in Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00469586 - Recruiting
Diabetes Mellitus
- To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given Together
ClinicalTrials.gov Identifier: NCT00318461 - Active, not recruiting
Type 2 Diabetes
- Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)
ClinicalTrials.gov Identifier: NCT00032487 - Active, not recruiting
Type 2 diabetes mellitus
- A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00449605 - Recruiting
Diabetes Mellitus, Type 2
- Pharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy Subjects
ClinicalTrials.gov Identifier: NCT00562250 - Not yet recruiting
Diabetes Mellitus, Type 2
- Phase III Study for Glimepiride + Metformin Hydrochloride (Amaryl M) Slow Release (SR)
ClinicalTrials.gov Identifier: NCT00437554 - Completed
Diabetes Mellitus, Type 2
- 24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00318656 - Completed
Non-Insulin-Dependent Diabetes Mellitus
- A Study of Pioglitazone HCl Versus Glimepiride in Subjects With Type 2 Diabetes Measuring the Progression of Atherosclerosis (CHICAGO)
ClinicalTrials.gov Identifier: NCT00225264 - Completed
Diabetes Mellitus, Type 2; Coronary Artery Disease
- Glimepiride Vs Metformin as Monotherapy in Pediatric Subjects With Type 2 Diabetes Mellitus
ClinicalTrials.gov Identifier: NCT00353691 - Completed
Type 2 Diabetes Mellitus
- Evaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients unresponsive to Maximum Dose Metformin & Thiazolidinedione
ClinicalTrials.gov Identifier: NCT00044447 - Completed
Diabetes Mellitus, Non-Insulin-Dependent

Not Signed In -


